InflaRx (IFRX) Treasury Shares (2016 - 2018)

InflaRx (IFRX) posted Treasury Shares of -$57069.8 for Q4 2018, down 115.1% sequentially from $377903.5 in Q4 2016.

InflaRx (IFRX) Treasury Shares (2016 - 2018) Analysis & Trends

InflaRx has reported Treasury Shares for 2 years, with the latest figure at -$57069.8 in Q4 2018.

Quarterly Treasury Shares changed N/A year-over-year to -$57069.8 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$57069.8 (changed N/A YoY) and the FY2018 annual result came in at -$59066.5, changed N/A from the prior year.
Treasury Shares declined to -$57069.8 in Q4 2018 per IFRX's latest filing, from $377903.5 in the prior quarter.
Over five years, Treasury Shares peaked at $377903.5 in Q4 2016 and troughed at -$57069.8 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	InflaRx	140.30 Mn	-43.96 Mn	2.74 Bn	-

Download Data